Factor II Deficiency Workup

1. Watson H, Perez A, Ayesu K, Musa F, Sarriera J, Madruga M, et al. Inherited factor II deficiency with paradoxical hypercoagulability: a case report. Blood Coagul Fibrinolysis. 2018 Mar. 29 (2):223-226. [QxMD MEDLINE Link].

2. Baudo F, de Cataldo F, Josso F, Silvello L. Hereditary hypoprothrombinaemia. True deficiency of factor II. Acta Haematol. 1972. 47(4):243-9. [QxMD MEDLINE Link].

3. Girolami A, Scarano L, Saggiorato G, et al. Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis. 1998 Oct. 9(7):557-69. [QxMD MEDLINE Link].

4. Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: an update. Semin Thromb Hemost. 2013 Sep. 39(6):596-606. [QxMD MEDLINE Link].

5. Harel R, Shani D, Donohoe K. A case of congenital prothrombin deficiency and idiopathic thrombocytopenic purpura in a pregnant female. Blood Coagul Fibrinolysis. 2016 Feb 15. [QxMD MEDLINE Link].

6. Bajaj SP, Rapaport SI, Barclay S, Herbst KD. Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management. Blood. 1985 Jun. 65(6):1538-43. [QxMD MEDLINE Link]. [Full Text].

7. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996 Nov 15. 88(10):3698-703. [QxMD MEDLINE Link]. [Full Text].

8. Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998 Apr. 79(4):706-8. [QxMD MEDLINE Link].

9. Atasay B, Arsan S, Gunlemez A, Kemahli S, Akar N. Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center. Pediatr Hematol Oncol. 2003 Dec. 20(8):627-34. [QxMD MEDLINE Link].

10. Irdem A, Devecioglu C, Batun S, Soker M, Sucakli IA. Prevalence of factor V Leiden and prothrombin G20210A gene mutation. Saudi Med J. 2005 Apr. 26(4):580-3. [QxMD MEDLINE Link].

11. Margaglione M, Brancaccio V, Giuliani N, et al. Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med. 1998 Jul 15. 129(2):89-93. [QxMD MEDLINE Link]. [Full Text].

12. Lalouschek W, Schillinger M, Hsieh K, et al. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke. 2005 Jul. 36(7):1405-9. [QxMD MEDLINE Link]. [Full Text].

13. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005 Feb 9. 293(6):715-22. [QxMD MEDLINE Link]. [Full Text].

14. Quick AJ. Congenital hypoprothrombinemia and pseudo-hypoprothrombinemia. Lancet. 1947. ii:379-82.

15. Shapiro SS, Martinez J, Holburn RR. Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin. J Clin Invest. 1969 Dec. 48(12):2251-9. [QxMD MEDLINE Link]. [Full Text].

16. Royle NJ, Irwin DM, Koschinsky ML, MacGillivray RT, Hamerton JL. Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat Cell Mol Genet. 1987 May. 13(3):285-92. [QxMD MEDLINE Link].

17. Degen SJ. The prothrombin gene and its liver-specific expression. Semin Thromb Hemost. 1992. 18(2):230-42. [QxMD MEDLINE Link].

18. Pollak ES, Lam HS, Russell JE. The G20210A mutation does not affect the stability of prothrombin mRNA in vivo. Blood. 2002 Jul 1. 100(1):359-62. [QxMD MEDLINE Link]. [Full Text].

19. Ceelie H, Spaargaren-van Riel CC, Bertina RM, Vos HL. G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3'-end formation. J Thromb Haemost. 2004 Jan. 2(1):119-27. [QxMD MEDLINE Link].

20. Sun WY, Witte DP, Degen JL, Colbert MC, Burkart MC, Holmbäck K, et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci U S A. 1998 Jun 23. 95(13):7597-602. [QxMD MEDLINE Link]. [Full Text].

21. Sun WY, Coleman MJ, Witte DP, Degen SJ. Rescue of prothrombin-deficiency by transgene expression in mice. Thromb Haemost. 2002 Dec. 88(6):984-91. [QxMD MEDLINE Link].

22. Narayanan S. Multifunctional roles of thrombin. Ann Clin Lab Sci. 1999 Oct-Dec. 29(4):275-80. [QxMD MEDLINE Link].

23. Zhou H, Gabazza EC, Takeya H, et al. Prothrombin and its derivatives stimulate motility of melanoma cells. Thromb Haemost. 1998 Sep. 80(3):407-12. [QxMD MEDLINE Link].

24. Akhavan S, Mannucci PM, Lak M, et al. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb Haemost. 2000 Dec. 84(6):989-97. [QxMD MEDLINE Link].

25. Sun WY, Burkart MC, Holahan JR, Degen SJ. Prothrombin San Antonio: a single amino acid substitution at a factor Xa activation site (Arg320 to His) results in dysprothrombinemia. Blood. 2000 Jan 15. 95(2):711-4. [QxMD MEDLINE Link]. [Full Text].

26. Wang W, Fu Q, Zhou R, et al. Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly. Haemophilia. 2004 Jan. 10(1):94-7. [QxMD MEDLINE Link].

27. Jayandharan G, Viswabandya A, Baidya S, et al. Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362 --> Thr (Prothrombin Vellore 1) mutation. J Thromb Haemost. 2005 Jul. 3(7):1446-53. [QxMD MEDLINE Link]. [Full Text].

28. Sun WY, Smirnow D, Jenkins ML, Degen SJ. Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia. Thromb Haemost. 2001 Apr. 85(4):651-4. [QxMD MEDLINE Link].

29. Lefkowitz JB, Weller A, Nuss R, et al. A common mutation, Arg457-->Gln, links prothrombin deficiencies in the Puerto Rican population. J Thromb Haemost. 2003 Nov. 1(11):2381-8. [QxMD MEDLINE Link].

30. Kling SJ, Jones KA, Rodgers GM. A second case of prothrombin Puerto Rico I in the United States. Am J Hematol. 2007 Jul. 82(7):661-2. [QxMD MEDLINE Link]. [Full Text].

31. Rouy S, Vidaud D, Alessandri JL, et al. Prothrombin Saint-Denis: a natural variant with a point mutation resulting in Asp to Glu substitution at position 552 in prothrombin. Br J Haematol. 2006 Mar. 132(6):770-3. [QxMD MEDLINE Link].

32. Kuijper PH, Schellings MW, van de Kerkhof D, Nicolaes GA, Reitsma P, Halbertsma F, et al. Two novel mutations in the prothrombin gene identified in a patient with compound heterozygous type 1/2 prothrombin deficiency. Haemophilia. 2013 Sep. 19(5):e304-6. [QxMD MEDLINE Link].

33. Bhat RV, Deshmukh CT. A study of Vitamin K status in children on prolonged antibiotic therapy. Indian Pediatr. 2003 Jan. 40(1):36-40. [QxMD MEDLINE Link]. [Full Text].

34. Baudo F, Redaelli R, Pezzetti L, et al. Prothrombin-antibody coexistent with lupus anticoagulant (LA): clinical study and immunochemical characterization. Thromb Res. 1990 Jan 15. 57(2):279-87. [QxMD MEDLINE Link].

35. Taddio A, Brescia AC, Lepore L, Rose CD. Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant hypoprothrombinemia syndrome (LAHPS). Clin Rheumatol. 2007 Dec. 26(12):2167-9. [QxMD MEDLINE Link].

36. Meireles E, Machado F, Teles L, Chumakova A, Sequeira J, Spínola A. A case report of severe bleeding due to lupus anticoagulant hypoprothrombinemia syndrome. J Thromb Thrombolysis. 2020 Feb. 49 (2):334-336. [QxMD MEDLINE Link].

37. Cote HC, Huntsman DG, Wu J, Wadsworth LD, MacGillivray RT. A new method for characterization and epitope determination of a lupus anticoagulant-associated neutralizing antiprothrombin antibody. Am J Clin Pathol. 1997 Feb. 107(2):197-205. [QxMD MEDLINE Link].

38. Vivaldi P, Rossetti G, Galli M, Finazzi G. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica. 1997 May-Jun. 82(3):345-7. [QxMD MEDLINE Link]. [Full Text].

39. Sreedharanunni S, Ahluwalia J, Kumar N, Bose SK, Dhawan R, Malhotra P. Lupus anticoagulant - hypoprothrombinemia syndrome: a rare cause of intracranial bleeding. Blood Coagul Fibrinolysis. 2016 Dec 22. [QxMD MEDLINE Link].

40. Foord A, Baca N, Buchbinder D, Mahajerin A. Lupus anticoagulant hypoprothrombinemia syndrome associated with severe thrombocytopenia in a child. Pediatr Blood Cancer. 2016 Nov 15. [QxMD MEDLINE Link].

41. Shimizu T, Ishiguro A, Takayanagi T, Matsui T, Tonegawa N, Maekawa T, et al. [A case of lupus anticoagulant hypoprothrombinemia syndrome following adenovirus gastroenteritis and mycoplasma pneumonia]. Nihon Rinsho Meneki Gakkai Kaishi. 2014. 37(1):55-60. [QxMD MEDLINE Link].

42. Nayer A, Ortega LM. Catastrophic antiphospholipid syndrome: a clinical review. J Nephropathol. 2014 Jan. 3(1):9-17. [QxMD MEDLINE Link]. [Full Text].

43. Meeks SL, Abshire TC. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment. Haemophilia. 2008 Nov. 14 (6):1159-63. [QxMD MEDLINE Link].

44. Doncarli A, Demiguel V, Guseva Canu I, Goulet V, Bayart S, Calvez T, et al. FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders. Eur J Epidemiol. 2019 May. 34 (5):521-532. [QxMD MEDLINE Link].

45. Klincheva M, Vilarova EA, Angjusheva T, Milev I, Idoski E, Mitrev Z. Endothelial Nitric Oxide Synthase T-786C Mutation, Prothrombin Gene Mutation (G-20210-A) and Protein S Deficiency Could Lead to Myocardial Infarction in a Very Young Male Adult. Open Access Maced J Med Sci. 2016 Mar 15. 4 (1):142-5. [QxMD MEDLINE Link].

46. Miyawaki Y, Suzuki A, Fujita J, et al. Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med. 2012 Jun 21. 366(25):2390-6. [QxMD MEDLINE Link].

47. Lechler E. Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, protein C protein S, or protein Z. Thromb Res. 1999 Aug 15. 95(4 suppl 1):S39-50. [QxMD MEDLINE Link].

48. Janjetovic S, Beckmann L, Holstein K, Rolling C, Thiele B, Schafhausen P, et al. Prevalence of definite antiphospholipid syndrome in carriers of the JAK2^V617F mutation. Thromb Res. 2021 Feb. 198:55-61. [QxMD MEDLINE Link].

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Christopher J Steen, MD Dermatologist, Private Practice

Christopher J Steen, MD is a member of the following medical societies: Alpha Omega Alpha, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Pere Gascon, MD, PhD Professor and Senior Consultant, Division of Medical Oncology, Institute of Hematology and Medical Oncology, Hospital Clinic; Director, Laboratory of Molecular and Translational Oncology, University of Barcelona Faculty of Biology, Spain

Pere Gascon, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, New York Academy of Medicine, New York Academy of Sciences, Royal College of Surgeons of Edinburgh, Royal European Academy of Doctors, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ronald A Sacher, MD, FRCPC, DTM&H Professor Emeritus of Internal Medicine and Hematology/Oncology, Emeritus Director, Hoxworth Blood Center, University of Cincinnati Academic Health Center

Ronald A Sacher, MD, FRCPC, DTM&H is a member of the following medical societies: American Association for the Advancement of Science, American Association of Blood Banks, American Clinical and Climatological Association, American Society for Clinical Pathology, American Society of Hematology, College of American Pathologists, International Society of Blood Transfusion, International Society on Thrombosis and Haemostasis, Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Perumal Thiagarajan, MD Professor of Medicine and Pathology and Immunology, Baylor College of Medicine; Director, Hematology Laboratory and Transfusion Medicine, Michael E DeBakey Veterans Affairs Medical Center

Perumal Thiagarajan, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Society for Biochemistry and Molecular Biology, American Society for Clinical Investigation, American Society of Hematology, Association of American Physicians, Royal College of Physicians

Disclosure: Nothing to disclose.

Paul Schick, MD † Emeritus Professor, Department of Internal Medicine, Jefferson Medical College of Thomas Jefferson University; Research Professor, Department of Internal Medicine, Drexel University College of Medicine; Adjunct Professor of Medicine, Lankenau Hospital

Paul Schick, MD is a member of the following medical societies: American College of Physicians, American Society of Hematology

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article